Affymetrix, Inc.
Affymetrix creates breakthrough tools for applications in the drug development process and pharmacogenomics. By applying the principles of semiconductor technology to the life sciences, Affymetrix has created the GeneChipmicroarray platform for both gene expression analysis (mRNA) and genetic analysis (DNA). The company's integrated system is setting the standard for basic research and target identification and is now being adopted in additional research applications, such as target validation and toxicogenomics, as well as in healthcare applications including clinical trials and health management. Affymetrix' current customers include pharmaceutical, biotechnology, agrochemical, diagnostic and consumer product companies as well as academic, government and other non-profit research institutions. Additional information on Affymetrix can be found at www.affymetrix.com.
Yap
Greg
G
Affymetrix, Inc., 3380 Central Expressway, Santa Clara, CA 95051, USA. greg_yap@affymetrix.com
D006801:Humans; D020411:Oligonucleotide Array Sequence Analysis / Q000295:instrumentation / Q000379:methods* / Q000639:trends; D012333:RNA, Messenger / Q000235:genetics; D013678:Technology, Pharmaceutical / Q000295:instrumentation / Q000379:methods* / Q000639:trends
D012333:RNA, Messenger